http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1076653-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc62792656aa2e858252e97e5ffaca79 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-78 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-78 |
filingDate | 1999-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2004-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_957fd58b157501ce0d6b194cfe8d937c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cc06ad0b67b47629069fabf5e4b713b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05a0b09d466b77f78d988050c0b9cb28 |
publicationDate | 2004-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1076653-B1 |
titleOfInvention | Novel cannabinoids selective for the cb2 receptor |
abstract | Disclosed are novel cannabinoids which are selective for the CB2 receptor. The novel cannabinoids comprise a substituted or unsubstituted tricyclic cannabinoid core and a substituted or unsubstituted C5-C8 carbocyclic ring, five to eight-membered heterocyclic ring or a seven to ten membered bicyclic ring system fused to the monhydroxylated phenyl ring of the cannabinoid core. Also disclosed are methods of suppressing the immune system in a subject by administering to the subject a (e.g. immunosuppressive amount) effective amount of a novel cannabinoid described above. |
priorityDate | 1998-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.